Literature DB >> 10967758

Radiation therapy for esophageal cancer.

M Suntharalingam1.   

Abstract

Radiation therapy continues to play a major role in the management of patients with esophageal carcinoma. This role continues to evolve based on the success of combined modality treatment regimens. During the past decade, the concurrent application of chemotherapy and radiation has gained acceptance as a standard of practice that offers patients an improved opportunity for long-term survival, whereas the ultimate benefit of trimodality therapy remains an unanswered question. The start of the twenty-first century brings the challenge of decreasing the toxicities associated with therapy and the need to improve therapeutic options. The recent advances in technology have positioned radiation oncology to achieve both of these goals.

Entities:  

Mesh:

Year:  2000        PMID: 10967758

Source DB:  PubMed          Journal:  Chest Surg Clin N Am        ISSN: 1052-3359


  1 in total

1.  S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma.

Authors:  Lawrence P Leichman; Bryan H Goldman; Pierre O Bohanes; Heinz J Lenz; Charles R Thomas; Kevin G Billingsley; Christopher L Corless; Syma Iqbal; Philip J Gold; Jacqueline K Benedetti; Kathleen D Danenberg; Charles D Blanke
Journal:  J Clin Oncol       Date:  2011-10-24       Impact factor: 44.544

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.